Absorption of the nerve agent VX (O-ethyl-S-[2(di-isopropylamino)ethyl] methyl phosphonothioate) through pig, human and guinea pig skin in vitro

Toxicology in Vitro

Volumn 20, Issue 8, 2006, Pages 1532-1536

  Dalton, Christopher H ^a   Hattersley, Ian J ^a   Rutter, Stephen J ^a   Chilcott, Robert P ^b  

^a DEFENCE SCIENCE AND TECHNOLOGY LABORATORY   (United Kingdom)

^b PUBLIC HEALTH ENGLAND   (United Kingdom)

Author keywords

Nerve agent; Percutaneous absorption; Skin; Species comparison; VX

Indexed keywords

2 PROPANOL; METHYLPHOSPHONOTHIOIC ACID S (2 DIISOPROPYLAMINOETHYL) O ETHYL ESTER;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DERMATOME; GUINEA PIG; HUMAN; HUMAN TISSUE; KINETICS; NONHUMAN; PHYSICAL CHEMISTRY; RODENT; SKIN ABSORPTION; SKIN PERMEABILITY; SWINE;

ADULT; ANIMALS; CHEMICAL WARFARE AGENTS; CHOLINESTERASE INHIBITORS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DIFFUSION CHAMBERS, CULTURE; GUINEA PIGS; HUMANS; MIDDLE AGED; ORGANOTHIOPHOSPHORUS COMPOUNDS; REGRESSION ANALYSIS; SKIN ABSORPTION; SWINE;

ANIMALIA; CAVIA PORCELLUS; RODENTIA; SUS SCROFA; SUS SCROFA DOMESTICA;

EID: 33749861610     PISSN: 08872333     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tiv.2006.06.009     Document Type: Article

References (27)

1. Atchinson C.R., Sheridan R.E., Duniho S.M., and Shih T.M. Development of a guinea pig model for low doe, long term exposure to organophosphorous nerve agents. Toxicol. Mech. Meth. 14 (2004) 183-194
2. Bartek M.J., and La Budde J.A. Percutaneous absorption in vitro. In: Maibach H. (Ed). Animal Models in Dermatology (1975), Churchill Livingstone, New York 103-120
3. Bartek M.J., La Budde J.A., and Maibach H.I. Skin permeability in vivo: comparison in rat, rabbit, pig and man. J. Invest. Dermatol. 58 (1972) 114-123
4. Brady, S.M., 2003. Factors affecting the in vitro skin absorption kinetics of a homologous series of alcohols in the presence of an aqueous receptor fluid. M.Sc. Thesis, University of Birmingham.
5. Bronaugh R.L., Stewart R.F., and Congdon E.R. Methods for in vitro percutaneous absorption studies: II. Animal models for human skin. Toxicol. Appl. Pharmacol. 62 (1982) 481-488
6. Chilcott R.P., Jenner J., Carrick W., Hotchkiss S.A.M., and Rice P. In vitro human skin absorption of bis-2-(chloroethyl)sulphide (sulphur mustard). J. Appl. Toxicol. 20 (2000) 349-355
7. Chilcott R.P., Jenner J., Hotchkiss S.A.M., and Rice P. In vitro skin absorption and decontamination of sulphur mustard: comparison of human and pig-ear skin. J. Appl. Toxicol. 21 (2001) 279-283
8. Chilcott R.P., Dalton C.H., Hill I., Davison C.M., Blohm K.L., Clarkson E.D., Jenner J., and Hamilton M.G. Skin absorption of the nerve agent VX: Part I. In vivo studies using the domestic white pig. Perspect. Percut. Penetr. 8a (2002) 110
9. Chilcott R.P., Dalton C.H., Hill I., Davison C.M., Blohm K.L., Clarkson E.D., and Hamilton M.G. Skin absorption of the nerve agent VX: Part II. In vitro studies using domestic white pig skin. Perspect. Percut. Penetr. 8a (2002) 109
10. Chilcott R.P., Dalton C.H., Hill I., Davidson C.M., Blohm K.L., and Hamilton M.G. Clinical manifestations of VX poisoning following percutaneous exposure in the domestic white pig. Human Exp. Toxicol. 22 (2003) 255-261
11. Dick I.P., and Scott R.C. Pig ear skin as an in vitro model for human skin permeability. J. Pharm. Pharmacol. 44 (1992) 640-645
12. Duncan E.J.S., Brown A., Lundy P., Sawyer T.W., Hamilton M., Hill I., and Conley J.D. Site specific percutaneous absorption of methyl salicylate and VX in domestic swine. J. Appl. Toxicol. 22 (2002) 141-148
13. Franz T. Percutaneous absorption: on the relevance of in vitro data. J. Invest. Dermatol. 64 (1975) 190-195
14. Galey W.R., Lonsdale H.K., and Nacht S. The in vitro permeability of skin and buccal mucosa to selected drugs and tritriated water. J. Invest. Dermatol. 67 (1976) 713-717
15. Gore A.V., Liang A.C., and Chien Y.W. Comparative biomembrane permeation of tacrine using Yucatan minipigs and domestic pigs as the animal model. J. Pharm. Sci. 87 (1998) 441-447
16. Marrs T.C., Maynard R.L., and Sidell F.R. Organophosphate nerve agents. In: Marrs T.C., Maynard R.L., and Sidell F.R. (Eds). Chemical Warfare Agents Toxicology and Treatment (1996), John Wiley, Chichester 83-100
17. Marzulli F.N., Brown D.W.C., and Maibach H.I. Techniques for studying skin penetration. Toxicol. Appl. Pharmacol. Suppl. 3 (1969) 76-83
18. Maynard R.L., and Beswick F.W. Organophosphorous compounds as chemical warfare agents. In: Ballantyne B., and Marrs T.C. (Eds). Clinical and Experimental Toxicology of Organophosphates and Carbamates (1992), Buterworth Heinemann, London 373-385
19. McGreesh A.H. Percutaneous toxicity. Toxicol. Appl. Pharmacol. Suppl. 2 (1965) 20-26
20. Rutter, S.J., 2003. Factors affecting the in vitro skin absorption kinetics of a homologous series of alcohols in the presence of an ethanolic receptor fluid. M.Sc. Thesis, University of Birmingham.
21. Simon G.A., and Maibach H.I. The pig as an experimental animal model of percutaneous permeation in man: qualitative and quantitative observations - an overview. Skin Pharmacol. Appl. Skin Physiol. 13 (2000) 229-234
22. Stoughton R.B. Animal models for in vitro percutaneous absorption. In: Maibach H. (Ed). Animal Models in Dermatology (1975), Churchill Livingstone, New York 121
23. Tregear R.T. Physical Function of the Skin (1966), Academic Press, New York
24. van der Schans M.J., Lander B.J., van der Wiel H., Langenberg J.P., and Benschop H.P. Toxicokinetics of the nerve agent (±) VX in anesthetized and atropinized hairless guinea pigs and marmosets after intravenous and percutaneous administration. Toxicol. Appl. Pharmacol. 191 (2003) 48-62
25. Wester R.C., and Noonan P.K. Relevance of animal models for percutaneous absorption. Int. J. Pharm. 7 (1980) 99-110
26. Wetherell J., Hall T., and Passingham S. Physostigmine and hyoscine improves protection against the lethal and incapacitating effects of nerve agent poisoning in the guinea pig. Neurotoxicology 23 (2002) 341-349
27. Wetherell J.R., and French M.C. A comparison of the decarbamoylation rates of physostigmine inhibited plasma and red cell cholinesterases of man with other species. Biochem. Pharmacol. 42 (1991) 515-520